Key Finding
Electroacupuncture significantly reduced post-stroke spasticity scores (MAS: MD=-1.06, P<0.001) through multiple mechanisms including neurotransmitter modulation, anti-inflammatory effects, and enhanced neuroprotection in preclinical models.
Researchers conducted a comprehensive review of 20 animal studies involving 388 subjects to understand how electroacupuncture (EA) helps reduce muscle stiffness and spasticity that often occurs after a stroke. Post-stroke spasticity causes involuntary muscle tightness that interferes with movement and daily activities, affecting many stroke survivors during recovery.
The study found that electroacupuncture significantly improved neurological function and reduced muscle spasticity compared to control groups. Animals receiving EA treatment showed better coordination, balance, and movement scores. The treatment also reduced brain swelling and the size of damaged brain tissue following stroke.
Researchers identified several biological mechanisms explaining these improvements. Electroacupuncture appeared to work by balancing important brain chemicals called neurotransmitters, particularly GABA and glutamate, which control muscle tone and nerve signaling. The treatment reduced inflammation in the brain by lowering inflammatory markers like IL-6 and TNF-α. It also protected brain cells from oxidative stress damage and supported the growth and repair of neurons by increasing protective factors like BDNF.
The evidence quality was moderate, with study scores averaging 6.1 out of 10. Some variation existed in treatment protocols, including which acupuncture points were used, electrical stimulation settings, and treatment duration, which may have affected results.
For stroke survivors experiencing muscle spasticity, these findings suggest electroacupuncture may offer meaningful benefits as part of a comprehensive rehabilitation program. The treatment appears to address multiple underlying causes of post-stroke spasticity simultaneously. If you're considering electroacupuncture for post-stroke recovery, consult with a licensed acupuncturist experienced in neurological rehabilitation and coordinate with your stroke care team.
This systematic review and meta-analysis evaluated electroacupuncture efficacy for post-stroke spasticity across 20 preclinical studies (n=388 animals). Quality assessment using SYRCLE and CAMARADES tools yielded mean scores of 6.1/10. Primary outcomes demonstrated significant improvements: Zea Longa score (MD=-1.05, 95% CI -1.30 to -0.80, P<0.001) and Modified Ashworth Scale (MD=-1.06, 95% CI -1.43 to -0.69, P<0.001). EA significantly reduced cerebral infarct volume, edema severity, and inflammatory markers (IL-6, TNF-α). Mechanistic findings revealed EA modulates GABAergic-glutamatergic neurotransmission, downregulating GABA-T and glutamate while upregulating GAD67 and GABA levels. Treatment enhanced antioxidant markers (GSH, SLC7A11, GPX4) and neurotrophic factors (BDNF, TrkB with mRNA expression). Publication bias was detected in MAS assessments; heterogeneity in waveform parameters, acupoint selection, and treatment duration likely contributed to outcome variability. Clinical translation requires protocol standardization and human trials validating these neuroprotective mechanisms.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Breast cancer patients who received preoperative auricular electroacupuncture for three days before surgery had significantly lower anxiety, better sleep, higher postoperative recovery quality scores, and reduced NSAID use compared to sham controls.
📌 Intraoperative electroacupuncture at PC6 and PC4 significantly reduced the incidence of slow flow/no-reflow during PCI for acute myocardial infarction from 26.7% in controls to 6.7% in the treated group (RR 0.2; P=.04).
📌 Perioperative TEAS at LI4, PC6, ST36, and SP6 significantly reduced postoperative fatigue syndrome incidence and fatigue scores in elderly patients undergoing laparoscopic radical gastrectomy, alongside lower pain scores, reduced opioid consumption, and favorable anti-inflammatory and antioxidant biomarker changes.